Xinhua Pharma’s OAB-14 Receives NMPA Approval for Phase I Alzheimer’s Study
China-based Shandong Xinhua Pharmaceutical Co., Ltd (SHE: 000756) has announced receiving approval from the National...
Cii Tech Secures Tens of Millions in Pre-Series A Funding for Mass Spectrometry
China Innovation Instrument (Cii Tech), a life sciences instrument maker based in Ningbo, has reportedly...
TechnoDerma Raises Series A+ Funding to Advance Dermatology Pipeline
TechnoDerma Medicines Inc., a Zhejiang-based developer of dermatology small molecules, has reportedly raised “tens of...
Konruns’ KC1036 Advances to Phase II Study for Lung Adenocarcinoma
Beijing-based Konruns Pharmaceutical Co., Ltd (SHA: 603590) has announced receiving approval from the National Medical...
Harbour BioMed’s HBM1020 Receives FDA Approval for US Phase I Study
Harbour BioMed (HKG: 2142), a global biotech company operating in the Netherlands, the United States,...
Porton Pharma Solutions to Invest EUR 50 Million in Slovenia Bio-Industry Park
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions is set to establish a...
ClouDr Partners with Shaanxi Pharmaceutical Firms for Integrated Healthcare Solutions
Hangzhou Kang Ming Information Technology Co., Ltd (HKG: 9955), better known as “ClouDr,” has announced...
Syneos Health Partners with Fosun Pharma to Commercialize Serplulimab in US
US-based Syneos Health (Nasdaq: SYNH) has revealed a strategic partnership with Fosun Pharma USA Inc.,...
Sanofi’s iGlarLixi Approved in China for Type 2 Diabetes Management
French pharmaceutical major Sanofi (NASDAQ: SNY) has announced that the National Medical Products Administration (NMPA)...
Roche’s Polivy Approved by China’s NMPA for Lymphoma Treatment
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that the National Medical Products...
China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs
The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round...
Med Vision Secures A+ Round Financing to Accelerate Digital Therapy Commercialization
Hangzhou-based Med Vision Technology Co., Ltd. has successfully completed an A+ round financing, raising several...
MSD China to Take Legal Action Against Market Infringement of Molnupiravir
Merck Sharp & Dohme (MSD, NYSE: MRK)’s China unit has issued a WeChat notification vowing...
Med Vision Secures Series A+ Funding to Expand Digital Therapy Portfolio
Med Vision, a Hangzhou-based digital therapy specialist, has reportedly raised “tens of millions” of renminbi...
Kexing Pharmaceutical Initiates Phase I Trial for IFN-Alpha-1b Inhalation Solution
China-based Kexing Pharmaceutical (SHA: 688136) has announced the enrollment of the first subject and dosing...
Bioantibody Bio Raises RMB 100 Million in Series A Funding Round
Bioantibody Biotechnology Co., Ltd, a Nanjing-based in vitro diagnostics (IVD) and biologic company, has reportedly...
Meihua Partners with Getein Biotech to Manufacture COVID-19 Antigen Tests
China-based Meihua International Medical Technologies Co., Ltd (NASDAQ: MHUA) has announced a strategic partnership with...
CSPC’s Cleviprex Approved for Clinical Study by China’s NMPA
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced receiving approval from the National Medical...
China’s Dental Implant VBP Tender Results in Significant Price Cuts
The results of the dental implant system-focused volume-based procurement (VBP) tender held in Sichuan have...
Takeda’s Mobocertinib Approved in China for EGFR Exon20ins NSCLC
Japan-based Takeda Pharmaceutical Co., Ltd’s (TYO: 4502) China unit has announced receiving marketing approval from...